Viewing Study NCT04628494


Ignite Creation Date: 2025-12-25 @ 1:39 AM
Ignite Modification Date: 2025-12-30 @ 11:12 AM
Study NCT ID: NCT04628494
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-12-02
First Post: 2020-11-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)
Sponsor: Genmab
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module